Thymalfasin (Thymosin alpha-1): legal
This page summarises the status of thymalfasin, sold as thymosin alpha-1, in the places checked; it is not legal advice, and it does not cover every country or state.
United States
Thymalfasin does not appear by name anywhere in the federal “Schedules of Controlled Substances”, read in full on 2026-11-19.[1] It is not an approved medicine in the United States. The FDA's page on bulk drug substances that may present significant safety risks lists “Thymosin-alpha 1 (Ta1)” under “Bulk drug substances nominated but withdrawn”, and explains: “This list of bulk drug substances previously in category 2 of the interim policies were withdrawn by the nominators”.[2] Its safety text stays on the page: “The safety-related information is inadequate for the agency to sufficiently understand the extent of any safety issues raised by the proposed compounded drug.”[2] Not being federally scheduled is not the same as being legal to sell for consumption, and state law was not checked for this page.
References
- 21 CFR part 1308, Schedules of Controlled Substances, full text as of 2026-11-13 (eCFR versioner, read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 04/22/2026), Wayback capture of 19 October 2026 — US Food and Drug Administration
Comments
Sign in to join the conversation.
No comments yet.